Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-11

FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for Omeprazole from Sandoz Inc, granting regulatory approval for changes to the generic product's labeling and/or in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omeprazole (Omeprazole)

Snippet

SUPPL AP for OMEPRAZOLE (OMEPRAZOLE)